| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GPR65 OR2B2 GPR37L1 OR5K4 OR5K3 GPR87 PTAFR OR11H12 GPR160 FZD6 CELSR3 OR4A8 OR11H1 OR10G3 GPR68 OR6C1 P2RY14 OR11H2 | 6.87e-05 | 884 | 144 | 18 | GO:0004930 |
| GeneOntologyMolecularFunction | G protein-coupled purinergic nucleotide receptor activity | 9.96e-05 | 13 | 144 | 3 | GO:0045028 | |
| Domain | Pan_app | 1.50e-05 | 7 | 143 | 3 | IPR003609 | |
| Domain | PAN | 1.50e-05 | 7 | 143 | 3 | PS50948 | |
| Domain | PAN_1 | 1.50e-05 | 7 | 143 | 3 | PF00024 | |
| Domain | Dopey_N | 5.82e-05 | 2 | 143 | 2 | PF04118 | |
| Domain | Dopey_N | 5.82e-05 | 2 | 143 | 2 | IPR007249 | |
| Domain | P2Y13_rcpt | 1.74e-04 | 3 | 143 | 2 | IPR008109 | |
| Domain | GPCR_Rhodpsn_7TM | GPR65 OR2B2 GPR37L1 OR5K4 OR5K3 GPR87 PTAFR OR11H12 GPR160 OR11H1 OR10G3 GPR68 OR6C1 P2RY14 OR11H2 | 1.96e-04 | 670 | 143 | 15 | IPR017452 |
| Domain | G_PROTEIN_RECEP_F1_2 | GPR65 OR2B2 GPR37L1 OR5K4 OR5K3 GPR87 PTAFR OR11H12 GPR160 OR11H1 OR10G3 GPR68 OR6C1 P2RY14 OR11H2 | 2.73e-04 | 691 | 143 | 15 | PS50262 |
| Domain | GPCR_Rhodpsn | GPR65 OR2B2 GPR37L1 OR5K4 OR5K3 GPR87 PTAFR OR11H12 GPR160 OR11H1 OR10G3 GPR68 OR6C1 P2RY14 OR11H2 | 2.77e-04 | 692 | 143 | 15 | IPR000276 |
| Domain | - | 3.46e-04 | 4 | 143 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 3.46e-04 | 4 | 143 | 2 | PS51139 | |
| Domain | GTF2I | 3.46e-04 | 4 | 143 | 2 | PF02946 | |
| Domain | GTF2I | 3.46e-04 | 4 | 143 | 2 | IPR004212 | |
| Domain | PAN_AP | 5.73e-04 | 5 | 143 | 2 | SM00473 | |
| Domain | G_PROTEIN_RECEP_F1_1 | GPR65 OR2B2 GPR37L1 OR5K4 OR5K3 GPR87 PTAFR OR11H12 GPR160 OR11H1 OR10G3 GPR68 OR6C1 P2RY14 | 7.92e-04 | 685 | 143 | 14 | PS00237 |
| Pubmed | 3.37e-10 | 21 | 153 | 6 | 16079250 | ||
| Pubmed | Identification of a melanoma susceptibility locus and somatic mutation in TET2. | 2.88e-06 | 7 | 153 | 3 | 24980573 | |
| Pubmed | Spurious transcription causing innate immune responses is prevented by 5-hydroxymethylcytosine. | 4.60e-06 | 8 | 153 | 3 | 36539616 | |
| Pubmed | 6.99e-06 | 104 | 153 | 6 | 10470851 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 9.79e-06 | 10 | 153 | 3 | 22973535 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 19234222 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 22837203 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 36591307 | ||
| Pubmed | Characterization of free alpha- and beta-chains of recombinant macrophage-stimulating protein. | 1.92e-05 | 2 | 153 | 2 | 10068459 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 22837197 | ||
| Pubmed | Recognition of single-stranded RNA viruses by Toll-like receptor 7. | 1.92e-05 | 2 | 153 | 2 | 15034168 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 8393443 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 27609031 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 31757807 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 24980820 | ||
| Pubmed | Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. | 1.92e-05 | 2 | 153 | 2 | 14976261 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 10728827 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 16961763 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 23497717 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 25232836 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 34070827 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 21482736 | ||
| Pubmed | Inhibiting endothelial cell Mst1 attenuates acute lung injury in mice. | 1.92e-05 | 2 | 153 | 2 | 39253972 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 32017081 | ||
| Pubmed | Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery. | 1.92e-05 | 2 | 153 | 2 | 22421433 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 24409221 | ||
| Pubmed | Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein. | 1.92e-05 | 2 | 153 | 2 | 8340069 | |
| Pubmed | Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice. | 1.92e-05 | 2 | 153 | 2 | 9486989 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 23845800 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 29654353 | ||
| Pubmed | Treatment with XMU-MP-1 erases hyperglycaemic memory in hearts of diabetic mice. | 1.92e-05 | 2 | 153 | 2 | 33887258 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 10931277 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 25938541 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 25653444 | ||
| Pubmed | Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65. | 1.92e-05 | 2 | 153 | 2 | 26550826 | |
| Pubmed | Mst1 regulates post-infarction cardiac injury through the JNK-Drp1-mitochondrial fission pathway. | 1.92e-05 | 2 | 153 | 2 | 29760744 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 21109237 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 35986423 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 26126547 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 18337753 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 31206688 | ||
| Pubmed | Mutual regulation between GDF11 and TET2 prevents senescence of mesenchymal stem cells. | 1.92e-05 | 2 | 153 | 2 | 37801347 | |
| Pubmed | Mast cell-mediated inhibition of abdominal neutrophil inflammation by a PEGylated TLR7 ligand. | 1.92e-05 | 2 | 153 | 2 | 22619481 | |
| Pubmed | Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy. | 1.92e-05 | 2 | 153 | 2 | 30708325 | |
| Pubmed | Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting Mst1. | 1.92e-05 | 2 | 153 | 2 | 27696525 | |
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 1.92e-05 | 2 | 153 | 2 | 15388857 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 33973242 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYD88 CPAMD8 RHBDF2 TRIO NAIP AAK1 RNF213 G2E3 ARHGEF16 CASZ1 KRCC1 IGF2 NT5C2 GPR137B IFT122 MCF2L RECK KDM4B DOP1A | 3.16e-05 | 1489 | 153 | 19 | 28611215 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NPC1 DAB2IP DOCK3 ABCA2 CLTCL1 RHBDF2 TRIO POLE GRK5 CASZ1 RGMA CELSR3 MTMR14 IL17RE ZNF335 MCF2L | 3.16e-05 | 1105 | 153 | 16 | 35748872 |
| Pubmed | Association analysis of 3p21 with Crohn's disease in a New Zealand population. | 5.43e-05 | 17 | 153 | 3 | 20307617 | |
| Pubmed | The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse. | 5.75e-05 | 3 | 153 | 2 | 10225971 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 38430683 | ||
| Pubmed | TRAF2 functions as an activator switch in the reactive oxygen species-induced stimulation of MST1. | 5.75e-05 | 3 | 153 | 2 | 26698664 | |
| Pubmed | TLR8 and its endogenous ligand miR-21 contribute to neuropathic pain in murine DRG. | 5.75e-05 | 3 | 153 | 2 | 30455267 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 17395874 | ||
| Pubmed | Humanized TLR7/8 expression drives proliferative multisystemic histiocytosis in C57BL/6 mice. | 5.75e-05 | 3 | 153 | 2 | 25229618 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 21115693 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 39273091 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 34460096 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 27496379 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 12606483 | ||
| Pubmed | Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. | 5.75e-05 | 3 | 153 | 2 | 11812998 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 33478938 | ||
| Pubmed | Mst1-mediated phosphorylation of Nur77 improves the endometrial receptivity in human and mice. | 5.75e-05 | 3 | 153 | 2 | 36623453 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 38288506 | ||
| Pubmed | The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. | 5.75e-05 | 3 | 153 | 2 | 8545120 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 25049204 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 28343969 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 1832957 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 25183307 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 35525373 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 21625574 | ||
| Pubmed | MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice. | 5.75e-05 | 3 | 153 | 2 | 27510910 | |
| Pubmed | Toll-like receptor 7 controls the anti-retroviral germinal center response. | 5.75e-05 | 3 | 153 | 2 | 21998589 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 38898027 | ||
| Pubmed | WASP and Mst1 coregulate B-cell development and B-cell receptor signaling. | 5.75e-05 | 3 | 153 | 2 | 32045478 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 27940445 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 34211474 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 29049365 | ||
| Pubmed | MyD88-Dependent Signaling Is Required for HOIP Deficiency-Induced Autoinflammation. | 5.75e-05 | 3 | 153 | 2 | 34253576 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 33057165 | ||
| Pubmed | An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. | 5.75e-05 | 3 | 153 | 2 | 22610069 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 20351139 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 12538524 | ||
| Pubmed | Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. | 5.75e-05 | 3 | 153 | 2 | 19339990 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 15665078 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 30063115 | ||
| Pubmed | Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury. | 5.75e-05 | 3 | 153 | 2 | 27218122 | |
| Pubmed | The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. | 5.75e-05 | 3 | 153 | 2 | 18820679 | |
| Pubmed | Genetic deletion of Mst1 alters T cell function and protects against autoimmunity. | 5.75e-05 | 3 | 153 | 2 | 24852423 | |
| Pubmed | Extracellularly delivered single-stranded viral RNA causes neurodegeneration dependent on TLR7. | 5.75e-05 | 3 | 153 | 2 | 22745379 | |
| Pubmed | Pds5B is required for cohesion establishment and Aurora B accumulation at centromeres. | 5.75e-05 | 3 | 153 | 2 | 24141881 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 12804176 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 15100712 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 37184367 | ||
| Pubmed | Role of Toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle. | 5.75e-05 | 3 | 153 | 2 | 24368419 | |
| Pubmed | Myeloid differentiation factor 88 signaling in donor T cells accelerates graft-versus-host disease. | 5.75e-05 | 3 | 153 | 2 | 31048358 | |
| Pubmed | The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity. | 5.75e-05 | 3 | 153 | 2 | 25848864 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 31976559 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 25771912 | ||
| Cytoband | 1q21.1 | 5.69e-05 | 62 | 153 | 4 | 1q21.1 | |
| GeneFamily | Neuroblastoma breakpoint family | 3.60e-11 | 23 | 103 | 7 | 662 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 8.26e-05 | 78 | 103 | 5 | 262 | |
| GeneFamily | Olfactory receptors, family 11 | 2.93e-04 | 23 | 103 | 3 | 159 | |
| GeneFamily | Ring finger proteins | 9.98e-04 | 275 | 103 | 7 | 58 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-07 | 171 | 153 | 8 | bf475a69db04d4a886e442704955c6a96ff0de46 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.50e-06 | 162 | 153 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | distal-3-Hematologic-Basophil/Mast_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.79e-06 | 193 | 153 | 7 | 23c6c798525dad43eff792727902ea562bf373be | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.79e-06 | 193 | 153 | 7 | efa91167dc7a59bf32addf90ffb7bf070b2a0151 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.95e-06 | 194 | 153 | 7 | 68d15917ae222cba0ad9e716d29eebb6c5f00f69 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 145 | 153 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 48 | 153 | 4 | 0b71435d798c6b25089a16b25d1d535f3c780d30 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-05 | 165 | 153 | 6 | 9d2bdc42c13c8c2a68889bec8612a1ce56f659fa | |
| ToppCell | BAL-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 2.46e-05 | 167 | 153 | 6 | 6c5aa9077ae7eb8887269d405972bd5b31596b19 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-05 | 167 | 153 | 6 | 1e2fc1637769405a61f4c7e44945712a1888a299 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-05 | 169 | 153 | 6 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-05 | 169 | 153 | 6 | ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 3.00e-05 | 173 | 153 | 6 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 175 | 153 | 6 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 175 | 153 | 6 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 179 | 153 | 6 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | COVID-19_Convalescent|World / Disease condition and Cell class | 3.86e-05 | 181 | 153 | 6 | a62115a8da486fc61225901c72b1ec70bcaf4c36 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 184 | 153 | 6 | 6388c47b7f1d8203e3069eba0e74107256dcae51 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 184 | 153 | 6 | d83ae1dc64aa1b27d3b524c137567418cc0ff8c6 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.26e-05 | 112 | 153 | 5 | 518b7ab98b988b23f3d0f0e1f4fe90a7068f9d87 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 187 | 153 | 6 | dba4924d914a7dcd4901142684ba920c2404860b | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 187 | 153 | 6 | 9688141beef4f62613d7a810c5872ccb9afc1a71 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 4.91e-05 | 189 | 153 | 6 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-05 | 189 | 153 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-05 | 189 | 153 | 6 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-05 | 189 | 153 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-05 | 189 | 153 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.05e-05 | 190 | 153 | 6 | 5c64b727669b23d2a23c8ad1d5d6caab7af37d56 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.05e-05 | 190 | 153 | 6 | 2434b8ad2976eab7d9147012c28454ab29670709 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_naive|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.05e-05 | 190 | 153 | 6 | e63945fa1dcd58bee129f1dd0c23b64a76241554 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_naive-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.05e-05 | 190 | 153 | 6 | fa65bc5a178ae0c80a9bd4b282e4539493128a64 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.05e-05 | 190 | 153 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.20e-05 | 191 | 153 | 6 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-05 | 191 | 153 | 6 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-05 | 191 | 153 | 6 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-05 | 192 | 153 | 6 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-05 | 192 | 153 | 6 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | distal-Hematologic-Basophil/Mast_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.51e-05 | 193 | 153 | 6 | f22d0a2ea6bbdd625909ccb6a89aca89ab670306 | |
| ToppCell | distal-Hematologic-Basophil/Mast_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.51e-05 | 193 | 153 | 6 | dcdc1498726c68bf590bf84cb81e5f7fb7ba4d78 | |
| ToppCell | 5'|World / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.67e-05 | 194 | 153 | 6 | 7f98f8bfd17a762a2bf748f1c689c7e941793917 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 195 | 153 | 6 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.84e-05 | 195 | 153 | 6 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 195 | 153 | 6 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.18e-05 | 197 | 153 | 6 | 608328608cef82adc867a449216839622253d486 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.53e-05 | 199 | 153 | 6 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | mLN-(2)_B_cell-(23)_Follicular_B_cell|mLN / shred on region, Cell_type, and subtype | 6.71e-05 | 200 | 153 | 6 | 659b49eeeb3e96b0a52663e60336ca4d76c83cfc | |
| ToppCell | mLN-B_cell-Follicular_B_cell|mLN / Region, Cell class and subclass | 6.71e-05 | 200 | 153 | 6 | 7f5dbd06f8643230dba45d6fa0258a13cb71f681 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 6.71e-05 | 200 | 153 | 6 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Caecum-B_cell-Follicular_B_cell|Caecum / Region, Cell class and subclass | 6.71e-05 | 200 | 153 | 6 | 5908e598c248ab89e576750767e9502385ee6322 | |
| ToppCell | Caecum-(2)_B_cell-(23)_Follicular_B_cell|Caecum / shred on region, Cell_type, and subtype | 6.71e-05 | 200 | 153 | 6 | 68ac9006a88e87c6b1f779ddc1e1a42cc81dc35e | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | CLTCL1 RNF31 FAAP24 RBKS OCRL CLSTN1 CHMP7 KBTBD4 PDS5A DOP1A | 7.21e-07 | 197 | 149 | 10 | 1148_DN |
| Drug | Hesperetin [520-33-2]; Up 200; 13.2uM; HL60; HG-U133A | 5.97e-06 | 196 | 149 | 9 | 2031_UP | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; HL60; HG-U133A | 6.48e-06 | 198 | 149 | 9 | 1553_UP | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 3.61e-06 | 7 | 140 | 3 | EFO_0020797 | |
| Disease | coronary artery disease | NPC1 DAB2IP TET2 PDS5B FNDC3B CLTCL1 TTC41P NBEAL1 EFCAB13 AAK1 RNF213 PRDM8 MALRD1 ZNF335 NT5C2 PKHD1 PLCL1 MCF2L KDM4B | 3.91e-06 | 1194 | 140 | 19 | EFO_0001645 |
| Disease | thioredoxin domain-containing protein 12 measurement | 3.51e-05 | 39 | 140 | 4 | EFO_0008298 | |
| Disease | blood urea nitrogen measurement | TRIB2 MCM6 RBKS ZNF318 CASZ1 PRDM8 IGF2 SLC25A43 PCDHGB4 PKHD1 | 6.28e-05 | 452 | 140 | 10 | EFO_0004741 |
| Disease | mean arterial pressure | ZNF423 RNF213 ZNF318 XKR6 CASZ1 PRDM8 NT5C2 PKHD1 PDS5A KDM4B | 1.41e-04 | 499 | 140 | 10 | EFO_0006340 |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 2.23e-04 | 25 | 140 | 3 | DOID:0050589 (implicated_via_orthology) | |
| Disease | urate measurement | DOCK3 POLE FAAP24 AAK1 MCM6 ZNF318 SLC7A9 PRDM8 IGF2 MALRD1 NT5C2 PKHD1 KDM4B | 3.50e-04 | 895 | 140 | 13 | EFO_0004531 |
| Disease | systolic blood pressure, alcohol drinking | 3.71e-04 | 128 | 140 | 5 | EFO_0004329, EFO_0006335 | |
| Disease | stomach cancer (is_implicated_in) | 3.89e-04 | 72 | 140 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | cysteine-rich with EGF-like domain protein 1 measurement | 4.69e-04 | 32 | 140 | 3 | EFO_0021870 | |
| Disease | Colorectal Carcinoma | TET2 CPAMD8 POLE FPGS GPR87 CHST8 DNALI1 GMCL2 IGF2 PKHD1 P2RY14 | 5.41e-04 | 702 | 140 | 11 | C0009402 |
| Disease | unipolar depression, systolic blood pressure | 5.62e-04 | 34 | 140 | 3 | EFO_0003761, EFO_0006335 | |
| Disease | alpha-2-macroglobulin measurement | 6.14e-04 | 8 | 140 | 2 | EFO_0020138 | |
| Disease | hepatocyte growth factor-like protein measurement | 7.81e-04 | 38 | 140 | 3 | EFO_0008154 | |
| Disease | pulse pressure measurement | NPC1 TET2 FNDC3B NBEAL1 ZNF423 EFCAB13 RNF213 ZNF318 CASZ1 PRDM8 MALRD1 NT5C2 ACCSL MCF2L FHL2 KDM4B | 9.57e-04 | 1392 | 140 | 16 | EFO_0005763 |
| Disease | Pulmonary Thromboembolisms | 1.43e-03 | 12 | 140 | 2 | C0524702 | |
| Disease | Pulmonary Embolism | 1.43e-03 | 12 | 140 | 2 | C0034065 | |
| Disease | inflammatory bowel disease (is_marker_for) | 1.43e-03 | 12 | 140 | 2 | DOID:0050589 (is_marker_for) | |
| Disease | cryptic phenotype measurement | 1.45e-03 | 47 | 140 | 3 | EFO_0021487 | |
| Disease | systolic blood pressure, alcohol consumption measurement | 1.45e-03 | 47 | 140 | 3 | EFO_0006335, EFO_0007878 | |
| Disease | cardiovascular disease | 1.57e-03 | 457 | 140 | 8 | EFO_0000319 | |
| Disease | osteitis deformans | 1.68e-03 | 13 | 140 | 2 | EFO_0004261 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 1.74e-03 | 50 | 140 | 3 | C0023453 | |
| Disease | Ciliopathies | 1.90e-03 | 110 | 140 | 4 | C4277690 | |
| Disease | breast cancer (is_marker_for) | 1.93e-03 | 185 | 140 | 5 | DOID:1612 (is_marker_for) | |
| Disease | mean arterial pressure, alcohol consumption measurement | 1.95e-03 | 52 | 140 | 3 | EFO_0006340, EFO_0007878 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 1.95e-03 | 52 | 140 | 3 | C0023452 | |
| Disease | Down syndrome (implicated_via_orthology) | 2.25e-03 | 15 | 140 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Rhabdomyosarcoma | 2.25e-03 | 15 | 140 | 2 | C0035412 | |
| Disease | health study participation | 2.43e-03 | 195 | 140 | 5 | EFO_0010130 | |
| Disease | cortical thickness | PDS5B CPAMD8 NBEAL1 ZNF423 ZNF318 XKR6 CHMP7 IGF2 MALRD1 NALF1 PCDHGB4 PKHD1 KDM4B | 2.52e-03 | 1113 | 140 | 13 | EFO_0004840 |
| Disease | smoking behavior, BMI-adjusted waist circumference | 2.77e-03 | 122 | 140 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | Benign neoplasm of stomach | 2.90e-03 | 17 | 140 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.90e-03 | 17 | 140 | 2 | C0496905 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.90e-03 | 17 | 140 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | Carcinoma in situ of stomach | 2.90e-03 | 17 | 140 | 2 | C0154060 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 2.90e-03 | 17 | 140 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | angina pectoris | 3.02e-03 | 125 | 140 | 4 | EFO_0003913 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 3.08e-03 | 61 | 140 | 3 | C1961102 | |
| Disease | Congenital Fiber Type Disproportion | 3.25e-03 | 18 | 140 | 2 | C0546264 | |
| Disease | age at onset, Parkinson disease | 3.25e-03 | 18 | 140 | 2 | EFO_0004847, MONDO_0005180 | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 3.25e-03 | 18 | 140 | 2 | OBA_2045065 | |
| Disease | chronotype measurement | NPC1 DOCK3 RAD18 TRIM35 ZNF318 CAV3 RNF123 NALF1 NT5C2 PKHD1 PLCL1 | 3.30e-03 | 882 | 140 | 11 | EFO_0008328 |
| Disease | retinal vasculature measurement | 3.35e-03 | 517 | 140 | 8 | EFO_0010554 | |
| Disease | Tinnitus | 3.48e-03 | 130 | 140 | 4 | HP_0000360 | |
| Disease | hypertension | 3.54e-03 | 307 | 140 | 6 | EFO_0000537 | |
| Disease | Calcium channel blocker use measurement | 3.55e-03 | 213 | 140 | 5 | EFO_0009930 | |
| Disease | Cannabis use, age at onset | 3.63e-03 | 19 | 140 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | response to methotrexate, neurotoxicity | 3.63e-03 | 19 | 140 | 2 | EFO_0011057, GO_0031427 | |
| Disease | DNA methylation | 4.18e-03 | 656 | 140 | 9 | GO_0006306 | |
| Disease | Stomach Carcinoma | 4.42e-03 | 21 | 140 | 2 | C0699791 | |
| Disease | Nephritis, Tubulointerstitial | 4.42e-03 | 21 | 140 | 2 | C0041349 | |
| Disease | pulse pressure measurement, alcohol drinking | 4.54e-03 | 70 | 140 | 3 | EFO_0004329, EFO_0005763 | |
| Disease | lymphocyte percentage of leukocytes | 4.57e-03 | 665 | 140 | 9 | EFO_0007993 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RFLEDNVCYALPVSC | 6 | Q7L4P6 | |
| NVCYALPVSCVRDFS | 11 | Q7L4P6 | |
| YLDPCTFEEERLLYC | 491 | Q4AC99 | |
| CCPLLNRFQLVFYLS | 491 | Q13075 | |
| PELREACDYLCISFE | 246 | Q9BSF8 | |
| ETYLLACLVDFFTNC | 161 | P49902 | |
| ACLVDFFTNCPRYTS | 166 | P49902 | |
| CYFTLPFGESQVAIC | 256 | Q2M2I8 | |
| VRDQFAYYSLQCLCP | 1216 | Q86V15 | |
| ASRPTCYLFLFNDVL | 521 | Q5VV41 | |
| YLRLPAQNCEETRFC | 46 | Q8N1L1 | |
| SNRSPYVLVCFQECE | 4276 | Q96DT5 | |
| CQLFLECSSFPVYIA | 751 | Q5JWR5 | |
| CRQDPSFLYRSLSCL | 336 | O43299 | |
| DCSPQFSQICSYEII | 191 | O94985 | |
| SVTSFFRYRQCLCVP | 11 | Q9NR28 | |
| IPFENCCTNETILRY | 146 | Q7L7V1 | |
| FCLSPTNLLRRFCHY | 1131 | Q00975 | |
| LLFDCLSVCYSESPV | 1551 | Q6ZS30 | |
| ACCLADIFRIYAPEA | 81 | Q9NTI5 | |
| TCDYFPLLQLACSDT | 176 | Q96RD1 | |
| ACCLADIFRIYAPEA | 91 | Q29RF7 | |
| DLLRCGICFEYFNIA | 21 | Q9NS91 | |
| CREYCQAIFRTDSSP | 161 | O95980 | |
| SRCEEYPLTRAFCQL | 696 | Q92621 | |
| LLSLFCPALCEQIRY | 21 | Q9UN71 | |
| EPCFESYISFLCKQL | 231 | Q01546 | |
| DPQFYTLSDVFCCNE | 186 | Q9H477 | |
| ELAFCKIINSYCVFP | 476 | Q5VWQ8 | |
| DLSYRLVFLACCVAP | 291 | Q14566 | |
| ALDCVSAPRIQLFCY | 201 | Q8NH07 | |
| DRALNFDPCCISYFT | 276 | Q9HBG6 | |
| SRFQETFCALDPCVL | 256 | O15232 | |
| ISDNENLFCECPRLY | 2351 | Q5T1H1 | |
| CYTTDPQIEREFCDL | 221 | Q2TV78 | |
| CLELFGRDYCFSVIP | 61 | Q8NCE2 | |
| PDLRDTCDYLCINFD | 196 | Q7Z5Y7 | |
| CFEECFRPVKQRYSV | 451 | Q9Y3R5 | |
| SYQIFPDPSDFDRCC | 41 | Q53QV2 | |
| EFLLPCLCIEASYLQ | 236 | Q8NFR9 | |
| PYSFTINFCQEECLR | 231 | P53370 | |
| AAARTEPYCAICTLF | 676 | O94953 | |
| FDAFICYCPSDIQFV | 161 | Q99836 | |
| SILRFITVCDYTNPC | 266 | Q99836 | |
| RTYFPFSCSCLNQLL | 236 | Q7L5L3 | |
| YVLPEVICRSCNFCR | 2151 | Q07864 | |
| FYFLCLAETTDCFLL | 101 | A6NET4 | |
| PCYECNRRFISSEQL | 356 | Q9NQV6 | |
| KTYSCIFCPESFDRL | 586 | Q9NQV6 | |
| DYFFCDIPAVLRLAC | 176 | Q8NGC4 | |
| LLSLFCPALCEQIRY | 21 | Q9Y5G0 | |
| FLSACNVCLDPIIYF | 301 | Q9BY21 | |
| FSLPCLRLFLVVTCY | 6 | Q7Z2Q7 | |
| PVFLTACIDYCLNFS | 111 | Q9UJ42 | |
| LQFLSRCPSCFYNLL | 91 | O15118 | |
| FYNLLNLFCELTCSP | 101 | O15118 | |
| SPCEADQFSCIYTLQ | 1901 | Q5VYJ5 | |
| ASRYFVLLPLCLCVF | 366 | O60353 | |
| CILYLLCFRQHPFED | 251 | O14976 | |
| NNYRESLPCTICLEF | 136 | Q7L622 | |
| IPLCRELACQYESLY | 1311 | Q8IZD9 | |
| PCAYEIRQFLDCSTT | 101 | Q8WYQ3 | |
| LCANSCPDERTFYLV | 186 | Q8WUX9 | |
| CYFCLPILFTVTCQL | 316 | O60883 | |
| RFEIRDLLPAAQYCC | 821 | Q53EP0 | |
| LTPDFYLSNRCCILY | 46 | Q9BTP7 | |
| AIICLSFSEYVCAPF | 126 | P82251 | |
| LFYFDEIPSRCLTCV | 1611 | Q8IZJ3 | |
| SRCCRYPLTVDFEAF | 311 | O95390 | |
| LAFASCCIAAYRPSE | 16 | P01344 | |
| YCPQCDALFDELTAR | 2131 | Q9BZC7 | |
| YSLCIRTFCNPLFAA | 121 | P56539 | |
| LREESPYCVVCFETL | 21 | Q14192 | |
| FYLICTYCPDLERQA | 906 | Q8IY85 | |
| CPVRRELYSQCFDEL | 121 | O14645 | |
| ENYTDCPELVGRCFL | 701 | O15068 | |
| CLDDFYRKFAPVCSI | 291 | Q8WUP2 | |
| CQFDYAVFCPNLTEV | 431 | Q05932 | |
| IRCQFFTYSLLPEDC | 326 | P03952 | |
| FQTQPYSLLRSCLDC | 336 | Q8N7A1 | |
| LSYCQFTRDCFSEKP | 101 | Q9NPI7 | |
| LFACPLSLEETDCYR | 91 | Q13683 | |
| CVDLRVCFSYIAVPS | 546 | Q13683 | |
| CVVFSCPLYSFDRAA | 1001 | Q13683 | |
| CYTTDPQIEREFCDL | 251 | P26927 | |
| IIRAECFLQEGFYSC | 421 | Q92674 | |
| FCETELDLCYSNPCR | 1431 | Q9NYQ7 | |
| CETRPGLECYIQFLD | 71 | P34947 | |
| YFFVEVQNIPTCLIC | 436 | Q86UP8 | |
| YFFVEVQNIPTCLIC | 436 | Q6EKJ0 | |
| ETCPYCFQLLVLDNS | 41 | Q32NC0 | |
| YCCFERVCLFKPITS | 421 | Q8N1G2 | |
| PALERLQRCTFCYDV | 1931 | A6NMZ7 | |
| IDPYLYIASCVNDLC | 336 | Q3ZCN5 | |
| QSSKPVRICDFCYDL | 196 | Q9H8W4 | |
| NFAATLECPIIFFCR | 251 | P12694 | |
| ALDCVSAPRIQLFCY | 201 | Q8NG94 | |
| ALDCVSAPRIQLFCY | 201 | B2RN74 | |
| ASCPIFVITIENYCN | 336 | Q9GZK3 | |
| CNLTVADLFYICSLP | 61 | Q15743 | |
| SFNCVADPVLYCFVS | 276 | Q15743 | |
| LRSVLFYTACLDPNF | 46 | Q9UPX6 | |
| FCNIYPLLDLECTDT | 176 | P0C604 | |
| PFFCELSIKDYTCLL | 306 | Q15406 | |
| LLYCFPVCLQFFTLT | 116 | O60478 | |
| ACCAFYSRNISPIEV | 901 | A6NKG5 | |
| PSRSFKEELLCAVCY | 11 | Q9UPQ4 | |
| CAVCYDPFRDAVTLR | 21 | Q9UPQ4 | |
| YCLAEVSPLRFRCTE | 11 | Q86TJ2 | |
| FRIEYEPLVACSSCL | 106 | O60934 | |
| CLELTDSCQPYRSAF | 611 | Q3BBV2 | |
| CLELTDSCQPYRSAF | 646 | P0DPF3 | |
| CLELTDSCQPYRSAF | 646 | Q6P3W6 | |
| CLELTDSCQPYRSAF | 1866 | Q6P3W6 | |
| CLELTDSCQPYRSAF | 3086 | Q6P3W6 | |
| CLELTDSCQPYRSAF | 306 | Q5TI25 | |
| CLELTDSCQPYRSAF | 1351 | A0A087WUL8 | |
| CLELTDSCQPYRSAF | 2571 | A0A087WUL8 | |
| CLELTDSCQPYRSAF | 31 | P0DPF2 | |
| CLELTDSCQPYRSAF | 1251 | P0DPF2 | |
| CLELTDSCQPYRSAF | 2471 | P0DPF2 | |
| CLELTDSCQPYRSAF | 3691 | P0DPF2 | |
| CLELTDSCQPYRSAF | 4911 | P0DPF2 | |
| CLELTDSCQPYRSAF | 306 | B4DH59 | |
| CLELTDSCQPYRSAF | 381 | B4DH59 | |
| CLELTDSCQPYRSAF | 456 | B4DH59 | |
| CLELTDSCQPYRSAF | 531 | B4DH59 | |
| CLELTDSCQPYRSAF | 606 | B4DH59 | |
| LLSTNCVLDPVIYCF | 281 | P25105 | |
| CRSCRTYINPFVSFL | 431 | O95486 | |
| LVCYNPLLDSFTRLC | 441 | Q9NVX7 | |
| TCLECSQRFQFEFPY | 156 | Q9NQV8 | |
| LDSRFLTFPLYICCN | 491 | Q8NEA9 | |
| YLYICEESSQCLFVP | 1836 | P08F94 | |
| CLRLFPCSAVQLAAY | 76 | Q8WUT9 | |
| FYFLCLAETTDCFLL | 101 | A6NMS3 | |
| HFFCDILPLYRLSCT | 176 | A6NMS3 | |
| ANVCLDPIIYFFLCQ | 286 | Q15391 | |
| DTPEFCAALRSYALC | 71 | Q96B86 | |
| PVICYELYQRCLDSA | 801 | Q01968 | |
| FAACLFTCYDLLRPD | 1566 | P53675 | |
| VSRLCSPCLIDYDFV | 331 | Q9H2A9 | |
| FIYEREQLEATCPQC | 806 | Q96EP0 | |
| FLNYQLRDCEASLFC | 2221 | Q63HN8 | |
| AFCELCTRPEVYFLL | 306 | Q15111 | |
| SYAVPALCCVFISFV | 471 | Q5GH73 | |
| QESIFLCEDLQCIYP | 66 | Q5W0Q7 | |
| CIFPRCIFSAIDAVY | 981 | Q8NI27 | |
| RSLCYPDTDVFLACF | 96 | Q96L33 | |
| CPFCQRELYEDSLLD | 141 | Q96EQ8 | |
| LADPCFQLRSICYLL | 1176 | Q5XPI4 | |
| AYELLAPCFQKALSC | 406 | Q96HA7 | |
| VFDISCYQESLAPCF | 91 | Q92519 | |
| RLKLCLDYVNSCFPF | 91 | Q6P2S7 | |
| QCLCEDQLYPLIGFF | 481 | P55017 | |
| CPDISFFQRATDYPC | 131 | Q9NVG8 | |
| LNCVADPILYCFVTE | 281 | Q8IYL9 | |
| YQRLISPDCCYDAFI | 881 | Q9NYK1 | |
| ICRDRSVFTALFYCP | 326 | Q8IYP9 | |
| QTALFCSACREYPSI | 156 | O60290 | |
| SKCPICLDRFDNVSY | 101 | Q9NS56 | |
| CSEVYLDCLQTFLPA | 676 | O43592 | |
| ISFLQELSCFVTRCY | 141 | Q2M389 | |
| CPYCSKRDFNSLAVL | 411 | Q2M1K9 | |
| TGERRYQCIFCLETF | 511 | Q8NAP3 | |
| LTCFPFTSRFCEKYE | 836 | Q6PJF5 | |
| TQYDFPSCRCVEQII | 1126 | Q6N021 | |
| GNISLYCCSIFDLPR | 126 | P51580 | |
| CSFCPYRTFREDFLL | 651 | Q9H4Z2 | |
| VPISGFYCQLCEEFL | 1131 | Q5VUA4 | |
| FYCQLCEEFLGDPIS | 1136 | Q5VUA4 | |
| LFLCLNDYETVSCPS | 156 | Q5QJ74 | |
| CLNICRLDFSFPDDY | 3001 | O75962 | |
| CLELERYLQSEPCYV | 36 | Q99612 | |
| YFEVTQFNCRKTIPC | 316 | B1AL88 |